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ABSTRACT. Bovine papillomaviruses (BPVs) are recognized as 
causal agents of benign and malignant tumors in cattle. Thirteen types 
of BPVs have already been described and classified into 3 distinct 
genera. Divergences in the nucleotide sequence of the L1 gene are 
used to identify new viral types through the employment of PCR 
assays with degenerated primers. In the present study, a method for 
identifying BPVs based on PCR-RFLP and DNA sequencing allowed 
the identification of a new putative Deltapapillomavirus, designated 
JN/3SP (JQ280500.1). The analysis of the L1 gene showed that this 
2459
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 13 (2): 2458-2469 (2014)
Clinical aspects of a new putative BPV
strain was most closely related to the BPVs -1, -2, -13 , and OaPV1 
(71-73% genetic similarity). In this study, we describe the detection of 
this new putative Deltapapillomavirus type and verify its phylogenetic 
position within the genus.
Key words: Bovine papillomavirus; New putative Deltapapillomavirus; 
Phylogenetics; PCR-RFLP; Sequencing
INTRODUCTION
Papillomaviruses (PVs) are oncogenic viruses, with a double-stranded circular DNA 
genome of approximately 8 kb. The family Papillomaviridae is currently divided into 29 gen-
era, formed by 190 papillomavirus types (de Villiers et al., 2004; Bernard et al., 2010), ac-
cording to their genomic organization (Chan et al., 1995). Species from different PV genera 
show less than 60% identity with the L1 gene nucleotide sequence, whereas species within a 
genus share 60-70% identify. A PV isolate is recognized as being a new type of isolate if the 
complete genome has been cloned, and the DNA sequence of the L1 gene differs by more than 
10% from the closest known PV type. Differences of 2-10% homology define a subtype, while 
differences of <2% homology define a variant (de Villiers et al., 2004; Bernard et al., 2010).
Bovine papillomaviruses (BPVs) are recognized as causal agents of benign and 
malignant tumors in cattle, such as cutaneous papillomas, fibropapillomas, urinary bladder, and 
esophageal cancer (Stocco dos Santos et al., 1998; Campo, 2003). To date, 13 types of BPVs 
have been characterized and classified into 3 distinct genera; namely, Delta, Epsilon, and Xi. In 
addition, each BPV has been associated with type-specific lesions (Borzacchiello and Roperto, 
2008). For example, the BPVs -1, -2, and -13 are classified in the Deltapapillomavirus genus. 
These viruses induce fibropapillomas, which are associated with the recruitment of sub-epithelial 
fibroblasts (Lunardi et al., 2013b). BPV-1 is generally associated with lesions of the teats and 
udder in cattle (Jarrett et al., 1984; Hatama et al., 2008). This type of virus is also associated 
with fibropapillomas in the animal penis, leading to necrosis, and loss of reproductive function 
(Gardiner et al., 2008). BPV-2 is a causal agent of malignant bladder tumors, in addition to 
cutaneous fibropapillomas (Jarrett et al., 1984). Both types of viruses have also been detected in 
the peripheral blood and reproductive tissues samples of cattle, indicating vertical transmission 
(Carvalho et al., 2003; Roperto et al., 2008; Diniz et al., 2009). Recently, the genome of a new 
BPV type (BPV-13) was fully sequenced and identified as a Delta-BPV (Lunardi et al., 2013b). 
It has been attributed to the ability of bovine Deltapapillomavirus to infect different host 
species, causing the equine sarcoid (Nasir and Reid, 1999; Nasir and Campo, 2008, Lunardi 
et al., 2013a). A greater number of BPV types (-3, -4, -6, -9, -10, -11, and -12) belong to the 
Xipapillomavirus genus, and are considered exclusively epitheliotropic viruses, inducing the 
formation of the so-called “true papillomas” (Jarrett et al., 1984; Hatama et al., 2011; Zhu et al., 
2012). In comparison, the BPVs -5 and -8 have the potential to induce fibropapillomas and true 
papillomas, being classified into a 3rd genus, the Epsilonpapillomavirus genus (Tomita et al., 
2007). BPV-7 is classified separately, to date (Ogawa et al., 2007).
The genome of most papillomavirus contains 8 genes divided into 3 regions; specifi-
cally, 1) early region, which encodes the transforming (E5, E6, and E7) and replication (E1 
and E2) of proteins; 2) long control region (LCR), which contains the origin of replication and 
the binding sites of multiple transcription factors; and 3) late region, which encodes the major 
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and minor proteins of the capsid (L1 and L2) (Zheng and Baker, 2006). The L1 gene is impor-
tant to papillomavirus taxonomy, because it is the most conserved gene within the PV genome 
and, therefore, has been used to identify new viral types (de Villiers et al., 2004; Bernard et 
al., 2010; Bernard, 2013).
The use of PCR assays with degenerated primers, followed by sequencing, has facili-
tated the identification of several PV types in human and other animal hosts, including BPVs 
in bovines (Hatama et al., 2011; Zhu et al., 2012). The 13 described BPV types, as well as 
other new putative PVs, have been confirmed by molecular biological methods, based on the 
nucleotide sequence diversity of the L1 gene (Ogawa et al., 2007; Claus et al., 2008; Hatama 
et al., 2011; Zhu et al., 2012). PCR assays using degenerated primers that amplify partial frag-
ments of the L1 gene, followed by sequencing, have demonstrated the presence of numerous 
new putative BPV types in cattle herds from different geographical regions (Silva et al., 2010). 
Investigations using the degenerated primers FAP59/FAP64 and MY09/MY11 identified 16 
new putative BPV types (FAP59/FAP64: BAA-1 to -4, BAPV-3 to -5, BAPV-7 to -10, BAPV-
11MY, and BPV/BRUEL-2, -3, -5; MY09/MY11: BAA-1 to -4, BAPV-2 to -5, BAPV-7 to -10, 
BAPPV11MY, and BPV/BR-UEL2 to 5) from healthy skin swabs or cutaneous warts of herds 
in Sweden, Japan, and Brazil (Ogawa et al., 2004; Claus et al., 2008; Hatama et al., 2008).
Different BPV types have already been detected in Brazil. Reports available from 
different regions of the country indicate a significant diversity of viral types in Brazil, 
implying significant economic losses due to the associated diseases (Roperto et al., 2008; 
Lindsey et al., 2009; Lunardi et al., 2010). Of note, the putative BPV type BR- UEL- 4 under 
accession No. EU293540, which is presently designated as BPV-13, was identified from a 
bovine skin wart and also in horse sarcoid tumor sample that were typically associated with 
the Deltapapillomavirus infection (Claus et al., 2008; Silva et al., 2010; Lunardi et al., 2013a). 
Here, we identify another new putative PV, designated JN/3SP (accession No. JQ280500.1), 
and determined its phylogenetic position into the Deltapapillomavirus genus. This description 
includes histological data of the lesions analyzed.
MATERIAL AND METHODS
Ethics statement
The protocols used in this study were approved by the Ethics Committee in Research 
from the Universidade Federal de São Paulo, Brazil, (Protocol No. 1829/09) assigned by the 
President of this committee. All efforts were made to minimize any suffering to the animals.
Animal selection
Four 6-year old Simmental cows, with disseminated cutaneous papillomatosis were 
selected. Wart fragments were collected in PBS buffer for DNA extraction.
Histopathological analysis
A fraction of all collected papilloma samples was fixed in 10% buffered formalin, 
embedded in paraffin, sliced into 5 µm sections, and stained with hematoxylin and eosin (HE). 
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DNA extraction and PCR
A fragment of each sample was subjected to DNA extraction, using a tissue and cells 
genomic Prep Mini Spin Kit (GE Healthcare, Buckinghamshire, UK). The quality of the DNA 
samples obtained was verified using the polymerase chain reaction (PCR) technique for the 
amplification of a 450 base pair (bp) fragment of the bovine β-globin, according to Yaguiu et al. 
(2008). Viral molecular identification was performed using the degenerate set of primers FAP. 
An approximately 478-bp segment of the L1 gene was amplified using the following primer 
sequences: forward: FAP59 (5'-TAA CWG TIG GIC AYC CWT ATT-3'); reverse: FAP64 (5'-
CCW ATA TCW VHC ATI TCI CCA TC-3'). The PCR was performed with slight modifications 
of a previously described protocol (Ogawa et al., 2004; Yaguiu et al., 2008). Specifically, the 
amplification reactions were performed in a Corbett CG1-96 thermocycler (Corbett Life Science, 
Sydney, Australia) with a GoTaq Master Mix (Promega, Madison, Wisconsin, USA) under the 
following conditions: 5 min at 95°C, followed by 35 cycles of 1.5 min at 95°C, 2 min at 52°C, 
and 1.5 min at 72°C, and a final extension step of 5 min at 72°C. The PCR products were analyzed 
on 2% agarose gel electrophoresis stained with GelRedTM (Nucleic Acid Gel Stain; Biotium, 
Hayward, CA, USA), and visualized under ultra-violet (UV) light.
Restriction analysis
The L1 FAP segment digestion profiles of BPVs-1 to -13 were generated by NEBcutter 
2.0 (Carvalho RF, personal communication) from all L1 complete nucleotide sequences 
available in the Genbank (http://www.ncbi.nlm.nih.gov/genbank/). Digestion reactions for 
RFLP profiling were performed with the DdeI enzyme (Table 1), following manufacturer 
protocols (New England Biolabs, Ipswich, USA). Cloned BPV-2 genome was used as positive 
controls. The PCR-RFLP products were analyzed on 2% agarose gel electrophoresis in TAE 
(tris/acetate/EDTA) buffer, stained with GelRedTM (Nucleic Acid Gel Stain), and visualized 
under UV light. PCR samples with abnormal or inconclusive RFLP patterns were subjected 
to repeat sequencing.
 BPV-1 BPV-2 BPV-3 BPV-4 BPV-5 BPV-6 BPV-7 BPV-8 BPV-9 BPV-10 BPV-11 BPV-12 BPV-13
L1 FAP fragment 475 bp 475 bp 473 bp 469 bp 469 bp 472 bp 484 bp 469 bp 469 bp 472 bp 475 bp 469 bp 475 bp
Fragments sized 264 316 319 324 469 151   81 316 319 63 420 351 109
   obtained with DdeI 159 159 154 145 321 403 469 153   90 55 118 316   50
Table 1. RFLP profiles for DdeI restriction enzyme of the BPVs-1 to -13.
Cloning and sequencing
The purified amplification products were cloned in TOPO TA cloning vector (pCRTM 
4-TOPOTM Vetor-Invitrogen, California, USA). Recombinant plasmids were used to transform 
competent DH5α E. coli cells, being subsequently recovered for sequencing reactions. Three 
independent sequencing reactions were created for each cloned PCR fragment in an ABI377 
PRISM Genetic Analyzer (Life Applied Biosystems, Foster City, California, USA). The qual-
ity of DNA sequences was checked, and overlapping fragments were assembled using the 
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BioEdit package software 7.0.9.0 (Hall, 1999). Assembled sequences with high quality were 
aligned using ClustalX1.83 with default gap penalties (Thompson et al., 1994).
Phylogenetic analysis
Homology analyses were performed with the NCBI database and BLAST (Altschul 
et al., 1997). Nucleotide and amino acid sequences from other BPV types, as well as from 
HPV-16 and other PVs, were retrieved from the GenBank for comparison with the sequences 
obtained here (JQ280500.1). The BioEdit software was used to identify the equivalent amino 
acid sequences. The sequenced dataset was analyzed with a Bayesian Markov-chain Monte 
Carlo (MCMC) approach (Yang and Rannala, 1997), using Mr Bayes 3.2 (Ronquist et al., 
2012). The search for the sequence data relied on the GTR + Γ model, with the number of 
gamma categories being set to 4 (Yang, 1993). Bayesian runs started from independent ran-
dom starting trees and were repeated 4 times. Markov chain Monte Carlo runs extended for 10 
million generations, with trees being sampled every 1000th generation.
RESULTS
The FAP PCR products were amplified from the 4 examined papilloma samples that 
had the expected molecular size. RFLP and subsequent DNA sequencing analysis identified 
BPV-2 in 1 sample (located in the head) (Figure 1) and, more relevantly, as yet unknown BPV 
isolate was identified in the other 3 samples (1 located in the head and 2 in the udder). This 
new putative type (JN/3SP) was genetically similar (Table 2) to DeltaBPVs, and to another 
Deltapapillomavirus type, OaPV1, which is known to infect ovines (Ovisaries).
Figure 1. FAP amplified product digestion: 2% agarose gel electrophoresis. Lanes M = GeneRuler Low Range 
DNA LadderTM; C+ = positive control (cloned BPV-2 genome). Lanes 1, 3, and 4 = undigested PCR sample; Lane 
2 = PCR digested sample (BPV-2). All samples correspond to the amplified products with generic primers FAP59/
FAP64, digested with DdeI.
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The histopathology of the skin lesion fragments of the animals (2 samples from the 
head and 2 from udders) infected with BPV-2, and the new putative Deltapapillomavirus 
JN/3SP showed a marked increase in epidermal koilocytosis, as well as other common 
features for this type of viral infection, such as papillomatosis, hyperkeratosis, acanthosis, 
and mild inflammatory infiltrates in the dermis and epidermis. The histopathology of the 
skin lesions of the animals infected with the putative new virus type showed a marked in-
crease in epidermal koilocytosis, in addition to other common features of viral infections 
(Figure 2).
Figure 2. Animal with papillomatosis and histopathological evaluation of skin lesion fragments. A. and B. Cutaneous 
papillomatosis on the face and udder. C. and E. Skin lesion infected with BPV-2 (5X and 10X objectives). D. and 
F. Skin lesion infected with new putative bovine (JN/3SP) (5X and 10X). Histopathological preparations with 
stained hematoxylin/eosin (HE): 1 = hyperkeratosis; 2 = acanthosis; 3 = inflammatory infiltrate in the dermis; 4 = 
koilocytosis; 5 = parakeratosis; Bar = 10 μm.
The partial L1 sequence (431 bp) of JN/3SP was compared to the L1 nucleotide 
sequences of all BPV types (1-13), as well as the L1 sequences of the other Deltapap-
illomavirus from different species (Table 3). Another comparison was done with oth-
er papillomavirus phylogenetically more distant, such as HPV-16 (Alfapapillomavirus) 
and SsPV1 (Dyodeltapapillomavirus) (Figure 3). Although the putative JN/3SP has been 
found in cattle, over 70% of the partial L1 gene showed similar genus Ovis aries Papil-
lomavirus 1, Deltapapillomavirus (Table 2).
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DISCUSSION
The FAP59/64 set was originally designed according to 2 relatively conserved regions 
of the L1 gene, and facilitated the characterization of a large diversity of HPV types (Forslund 
et al., 1999). One of the first descriptions of putative new types in bovines employing generic 
primers was published in 2002 (Antonsson and Hansson, 2002). Ogawa et al. (2004) reported 
the identification of authentic and putative BPV types in both lesions and healthy tissue. The 
authors also found that the FAP59/64 generic primer was more efficient at detecting PV com-
pared to the MY09/11 primer set. Hence, the identification of the new putative JN/03SP was 
carried out using FAP. These primers enable us to suggest a new HPV type, and to test the ef-
fectiveness of RFLP techniques for BPV screening and typing (Carvalho et al., 2003).
Figure 3. Phylogenetic Bayesian tree of FAP L1 ORF, including the BPV- JN/3SP (GenBank accession No. 
JQ280500.1). The tree is divided into the previously determined genera Deltapapillomavirus (BPV-1,-2 and 
-13, OvPV1, RtPV1, AaPV1, BpPV1, CcPV1, OaPV1, and OaPV2), Epsilonpapillomavirus (BPV-5 and -8), 
Xipapillomavirus (BPV-3, -4, -6, -9, -10, -11, -12), the undesignated BPV-7 and HPV-16. Numbers at nodes are 
Bayesian posterior probabilities. Scale bar represents the number of estimated changes per position for a unit 
of branch length. The following reference sequences were used: BPV-1 (X02346), BPV-2 (PPB2CG), BPV-3 
(AJ620207), BPV-4 (X05817), BPV-5 (AJ620206), BPV-6 (AJ620208), BPV-7 (DQ217793), BPV-8 (DQ098913), 
BPV-9 (AB331650), BPV-10 (AB331651), BPV-11 (AB543507), BPV-12 (JF834523), BPV-13 (JQ798171), UEL- 
2, -3 and -5 (EU293538, EU293539, and EU293541, respectively), HPV-16 (K02718), AaPV1 (M15953), CcaPV1 
(EF680235), OaPV1 (U83594), OaPV2 (U83595), OvPV1 (M11910), RtPV1 (AF443292), SsPV1 (EF395818).
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The Papilomavirus Nomenclature Committee (14th International Papillomavirus Con-
ference, Quebec City, Quebec, Canada) specified that: “The isolated novel sequences were 
called putative new PV types instead of PV types, since PCR products represent only part of the 
L1 gene” (Antonsson and Hansson, 2002; de Villiers et al., 2004). Analysis of the FAP L1 ORF 
sequence has shown that the JN/3SP strain is closely related to BPV-1, -2, and -13 (72-73% ge-
netic similarity). However it also showed 71% of similarity with OaPV1. Although it is known 
that most new types of PV shows less than 60% sequence identity to types from other genera, the 
percentage identity is only used as a general criteria to define the PV genus. For instance, the as-
signment of PV types to species and genera cannot be determined just by a computer algorithm, 
but requires curation, i.e., interpretation based on phylogeny, genome organization, biology, and 
pathogenicity (Bernard, 2013).
The phylogenetic analysis based on amino acid sequence alignments yielded a tree with 
a very similar topology to that based on nucleic acid sequence alignments (data not shown). 
The identification of this new putative as a Delta type was performed through a methodologi-
cal approach that addresses the correlation between the viral identity and the histopathological 
findings associated with the infection. Hence, macroscopic and histological data indicate that the 
collected lesions have fibropapilloma characteristics. Overall, these data indicate that JN/3SP 
represents a new Deltapapillomavirus. Thus, JN/3SP could be considered as the 2nd Brazilian 
Deltapapillomavirus isolate, after the new putative BR-UEL-4, currently named BPV-13 (Claus 
et al., 2008; Lunardi et al., 2013b). Similar to BPV-13, JN/3SP was identified from warts on the 
different body parts (head and udder) of different livestock in this study, indicating its pathogenic 
potential to induce cutaneous lesions (Lunardi et al., 2013b).
Compared to other BPV genera, BPV Deltapapillomavirus has the ability to infect dif-
ferent host species, causing equine sarcoid (Nasir and Reid, 1999; Nasir and Campo, 2008, 
Lunardi et al., 2013a). Equine sarcoid is a common horse epithelial tumor, the etiology of which 
has been previously associated with BPV-1 and, less frequently, with BPV-2 (Claus et al., 2008; 
Nasir and Campo, 2008). To date, this ability to infect different host species has been attributed 
exclusively to BPV-1 and BPV-2 (Nasir and Reid, 1999; Nasir and Campo, 2008). However, 
Silva et al. (2010) identified BR-UEL-4 (BPV-13) from both skin papillomas of cows and equine 
sarcoid samples. This observation indicates that this new Deltapapillomavirus type might also 
be associated with the development of equine sarcoids as well (Lunardi et al., 2013a). This phe-
nomenon could also be the case for JN/3SP; however, further studies are necessary to establish 
its potential to infect equine hosts, in addition to other potential livestock hosts.
Brazil has a high standing in the world market of bovine meat; yet, bovine papillomatosis 
is a persistent disease among Brazilian cattle. Therefore, this study aimed to obtain a better under-
standing about the clinical aspects related to BPV infection and its diagnosis. Hence, our findings 
are highly relevant for the development of new sanitary measures, including vaccines. At present, 
the typing of BPV is considered a laborious task, due to the presence of unknown viral types, in 
addition to co-infections in the infected samples that require the employment of cloning and DNA 
sequencing techniques. Our results provide evidence supporting the effectiveness of the PCR-
RFLP/sequencing procedure for the detection and identification of new BPV types.
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